(Press-News.org) Coral reefs are teeming with life: they are home to over a third of all marine animal and plant species on Earth, despite covering less than one percent of the ocean floor. However, this immense diversity is under threat from rising ocean temperatures. Since the 1950s, half of the world’s coral population has already disappeared.
Beyond the reef’s visible inhabitants, countless microorganisms are also under threat. These often live in symbiosis with corals, sponges and other reef dwellers, which benefits them both. To defend against pathogens, predators and competitors, microbes produce a vast arsenal of natural products that could be of great benefit to humankind.
The magnitude of the potential loss of this “natural pharmacy” is demonstrated by a new study published in the journal Nature. Conducted by ETH research groups led by Shinichi Sunagawa and Jörn Piel, in cooperation with Lucas Paoli from EPFL and the Tara Pacific Consortium, this study identified new microbial species in corals which have the ability to produce novel substances.
Samples reveal a multitude of microbes
The researchers examined more than 800 coral samples collected ten years ago during an expedition by the research vessel Tara across the Pacific Ocean. Most of these samples came from reef-building fire or stony corals.
The team first sequenced fragments of microbial DNA from the samples. Using high-performance computers at ETH Zurich, they then reconstructed the genomes of 645 different species of bacteria and archaea. “For over 99 percent of these species, no genomic information was previously available. Essentially, they were unknown to science,” says Sunagawa.
Every coral has its own microbiome
A comparison with open-ocean water samples showed that these microorganisms are not widely distributed across the Pacific; instead, they are found only within the reef. Furthermore, they tend to be restricted to a particular type of coral, with hardly any overlap between different coral genera. Sunagawa notes that these microorganisms typically inhabit the surface and gastric cavity of their coral hosts, forming a complex ecosystem – similar to the skin and gut microbiome in humans.
Genetic blueprints for natural products
However, the researchers were not content with simply describing new species; they also wanted to investigate the biochemical substances that these microbes might produce. By closely examining the genetic material for the “blueprints” behind these natural products, they discovered hidden treasure.
“We found more potential for the production of natural products in the genomes of coral reef microorganisms than we had previously found across the entire open ocean,” says Sunagawa. One reason for this may be the high density of life in coral reefs: in such a crowded environment, an organism with a versatile chemical defence arsenal has a clear competitive advantage.
Only a fraction discovered so far
For Sunagawa, these findings are only the beginning: “In the latest study, we examined corals from just three genera. In total, however, there are several hundred known genera, comprising several thousand species.” The microbiomes of other species-rich marine organisms, such as sponges, molluscs and algae, have also not yet been sufficiently researched.
The researchers are deeply concerned about the extent of these knowledge gaps, and their implications. If biodiversity in coral reefs continues to decline, it will mean the irretrievable loss of thousands of mostly unknown microbial species.
“Molecular research on coral reefs offers enormous potential for biotechnological and medical applications,” says Piel. “We are under time pressure to tap into and protect this potential,” urges Sunagawa. It is therefore absolutely vital for the protection of coral reefs to include the microbiome too.
END
An endangered natural pharmacy hidden in coral reefs
2026-02-25
ELSE PRESS RELEASES FROM THIS DATE:
The Frontiers of Knowledge Award goes to Charles Manski for incorporating uncertainty into economic research and its application to public policy analysis
2026-02-25
The BBVA Foundation Frontiers of Knowledge Awards in Economics, Finance and Management has gone in this eighteenth edition to Charles F. Manski for his pioneering contributions to the measurement of uncertainty in economic research and its application to public policy analysis. The professor at Northwestern University (Chicago, United States) is described by the committee as a “foundational figure” in the development of modern methods that have transformed how economists infer conclusions from data, report degrees of uncertainty in their models, ...
Walter Koroshetz joins Dana Foundation as senior advisor
2026-02-25
NEW YORK, February 24, 2026 – The Dana Foundation today announced Walter Koroshetz, M.D., FAAN, will join the organization as a senior advisor, effective March 1, in support of its mission to advance neuroscience that benefits society and reflects the aspirations of all people. Koroshetz, who oversaw the federal government’s largest neuroscience research portfolio as director of the National Institute of Neurological Disorders and Stroke (NINDS), will work with the Foundation’s leadership to guide science funding collaborations and support for early-career scholars and ...
Next-generation CAR-T designs that could transform cancer treatment
2026-02-25
“CAR T-cell therapy has emerged as a particularly promising cancer-specific treatment strategy.”
BUFFALO, NY – February 25, 2026 – A new editorial perspective was published in Volume 17 of Oncotarget on February 20, 2026, titled “CAR-T therapy: Trailblazing CAR(ing) in cancer treatment.”
Led by Uzma Saqib — with corresponding author Krishnan Hajela from the School of Life Sciences, Devi Ahilya Vishwavidyalaya — the perspective reviews recent clinical and translational advances in chimeric antigen receptor T-cell (CAR-T) therapy and highlights both its promise ...
As health care goes digital, patients are being left behind
2026-02-25
Patients are now expected to navigate much of their care online — from seeing their doctor on a screen to booking appointments, refilling prescriptions, and checking test results through health care portals.
Yet, according to a new study by UC San Francisco, most health systems are skipping a crucial step: asking whether their patients have the access and skills to use these digital tools.
The researchers surveyed nearly 150 clinicians and informatics leaders from health care systems across the country during the first half of 2024. Just 44% said they asked their patients if they could use digital devices. Among the ...
A clinicopathologic analysis of 740 endometrial polyps: risk of premalignant changes and malignancy
2026-02-25
Background and objectives
Endometrial polyp (EMP) is one of the most common diagnoses in the evaluation of women with abnormal uterine bleeding. Understanding the malignancy risk associated with EMPs and related risk factors is essential for guiding both pathology practice and clinical management. This study aimed to explore risk factors for malignancy in EMPs.
Methods
The pathology database was searched for women diagnosed with EMP between 2021 and 2022. Patient age, polyp size, background endometrium, recurrence, and (if applicable) cancer types were recorded. Immunohistochemistry (IHC) for p53 and p16 was performed on selected cases. Risk factors for malignancy were analyzed using Chi-square ...
Gibson Oncology, NIH to begin Phase 2 trials of LMP744 for treatment of first-time recurrent glioblastoma
2026-02-25
WEST LAFAYETTE, Ind. and MIAMI — Gibson Oncology, a clinical-stage private pharmaceutical company headquartered in Miami, announced it has entered Phase 2 clinical trials with LMP744 for the treatment of first-time recurrent glioblastoma patients.
The company is focused on advancing its novel small molecules with dual-action inhibition of topoisomerase 1 and reduction of overexpression of the cMYC oncogene.
“The primary endpoint of the study is to evaluate tumor regression in patients with recurrent glioblastoma. Secondary endpoints will evaluate parameters such as progression-free survival, biological changes in glioblastoma tissues obtained pre- and post-treatment, ...
Researchers develop a high-efficiency photocatalyst using iron instead of rare metals
2026-02-25
Photocatalysts facilitate chemical reactions by absorbing light. Metal-based photocatalysts are widely used in organic synthesis due to their durability and the ability to tune their function by modifying the ligands attached to the central metal atom.
Most metals used in photocatalysts, such as ruthenium and iridium, are rare and expensive. Researchers at Nagoya University, Japan, previously developed an iron-based alternative, but it required large amounts of costly chiral ligands, which act as spatial ...
Study finds no evidence of persistent tick-borne infection in people who link chronic illness to ticks
2026-02-25
When researchers studied Norwegians who thought tick bites caused their chronic health problems, they found no objective evidence linking the symptoms to ticks.
The same study finds that health problems reported by participants were associated with little physical activity and low labour force participation.
Many Norwegians pull ticks from their bodies every single summer. Roughly 2 per cent of those who are bitten are infected by a bacterium that leads to Lyme disease.
The disease can start with a rash that eventually spreads in the skin with a ring-shaped pattern. In some people, the disease can develop into facial paralysis, meningitis or other ...
New system tracks blockchain money laundering faster and more accurately
2026-02-25
An advanced detection system to identify and trace blockchain funds connected with criminal activity has been presented today at the Annual CyberASAP Demo Day in London.
The system, called SynapTrack, enables faster and more accurate detection of fraudulent activity using blockchains and cryptocurrencies, where traditional anti-money laundering and counter-terrorist financing systems struggle to keep pace.
Although current fraud detection methods pick up unusual activity, they deliver an extremely high rate (40%) of false positive reports. These require manual checking by compliance professionals, resulting in backlogs in identifying and acting ...
In vitro antibacterial activity of crude extracts from Tithonia diversifolia (asteraceae) and Solanum torvum (solanaceae) against selected shigella species
2026-02-25
Background and objectives
Infectious diarrhea is a gastrointestinal illness that results in around 1.7 billion cases and 525,000 deaths annually, particularly among children under five, according to the World Health Organization. While some Cameroonian medicinal plants show promise for treating diarrhea, many plants are used without established scientific evidence of their efficacy. These plants include Tithonia diversifolia (T. diversifolia) and Solanum torvum (S. torvum), which are traditionally used to treat diarrheal symptoms. This study sought to investigate the anti-Shigella activity of leaf ...